Brussels, 03 Feb 2004
Despite ongoing investment in technologies to support preclinical research, the declining rate of drug discovery continues to pose real problems for the pharmaceuticals industry.
To address this issue, a conference aimed at examining the development and use of tools for preclinical development will be held in Berlin, Germany, on 26 and April.
The event will focus specifically on predictive modelling and compound selection, and will feature contributions from pharmaceutical experts working in the field.
For further information, please consult the following web address: